Science related (Medical) Cannabinoid Pharma Company Backed by Snoop Dogg Heads for London IPO by Sophia Vida May 19, 2021 Oxford Cannabinoid Technologies (OTC) will be making its debut on the London Stock Exchange soon. The pharmaceutical company, which is developing cannabinoid-based prescription medicines, said this week that it had raised £16....
Featured Canopy Growth Sues GW Pharmaceuticals Over Infringement by Sophia Vida December 25, 2020 One of Canada's top marijuana producers, Canopy Growth Corp., is taking Britain-based GW Pharmaceuticals to court in the U.S. According to Canopy Growth, GW Pharmaceuticals has infringed upon their intellectual property. In a c...
Science related (Medical) First FDA Approved Marijuana-Derived Epilepsy Drug Sees Stellar Sales by Sophia Vida August 07, 2019 Gw Pharmaceuticals is the company behind Epidiolex, the first FDA approved epilepsy drug that is cannabis derived. The company announced on Tuesday that sales of the drug had more than doubled compared to the previous quarter. ...
Trends & Articles The First FDA Approved Cannabis Based-Medication Epidiolex Becomes Available in the U.S. by Sophia Vida November 02, 2018 It was just this past summer that the Food and Drug Administration approved GW Pharmaceuticals' Epidiolex, the first cannabis-based drug to treat twot ypes of epileptic syndroms: Dravet syndrome and Lennox-Gastaut syndrome. It ...
Spotlight Stock The Drug Enforcement Administration Gives Green Light to Marijuana Drug Epidiolex by Sophia Vida September 27, 2018 The Drug Enforcement Administration (DEA), the top drug regulator in the nation, has done something it hasn't done in almost fifty years. The agency has changed its position on cannabis for the first time in 46 years and announ...
Spotlight Stock The U.S. FDA Approves First Marijuana-Based Medicine by Sophia Vida June 26, 2018 The Food and Drug Administration made history on Monday by approving the nation's very first drug derived from cannabis called Epidiolex. GW Pharmaceutical's Epidiolex is made of CBD, a component of marijuana that provides no h...
Spotlight Stock FDA May Soon Approve a Prescription Drug Made From Marijuana by Sophia Vida June 21, 2018 GW Pharmaceuticals may soon see its epilepsy drug, Epidiolex, approved by the Food & Drug Administration to be a prescription drug. The drug is made from a component of cannabis that doesn't give the user the "high," and is...
Trends & Articles Study Finds that High-Strength Marijuana is Now Dominating U.K’s Illegal Market by Sophia Vida March 03, 2018 According to a study by King's College London and GW Pharmaceuticals, high potency cannabis is now dominating the illegal market in the UK. Samples have revealed a huge rise in highly psychoactive strains. The research has foun...